Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor

Jin Peng Sun, Alexander A. Fedorov, Seung Yub Lee, Xiao Ling Guo, Kui Shen, David S. Lawrence, Steven C. Almo, Zhong-Yin Zhang

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

Protein-tyrosine phosphatase 1B (PTP1B) has been implicated as an important regulator in several signaling pathways including those initiated by insulin and leptin. Potent and specific PTP1B inhibitors could serve as useful tools in elucidating the physiological functions of PTP1B and may constitute valuable therapeutics in the treatment of several human diseases. We have determined the crystal structure of PTP1B in complex with compound 2, the most potent and selective PTP1B inhibitor reported to date. The structure at 2.15-Å resolution reveals that compound 2 simultaneously binds to the active site and a unique proximal noncatalytic site formed by Lys-41, Arg-47, and Asp-48. The structural data are further corroborated by results from kinetic analyses of the interactions of PTP1B and its site-directed mutants with compound 2 and several of its variants. Although many of the residues important for interactions between PTP1B and compound 2 are not unique to PTP1B, the combinations of all contact residues differ between PTP isozymes, which provide a structural basis for potent and selective PTP1B inhibition. Our data further suggest that potent, yet highly selective, PTP1B inhibitory agents can be acquired by targeting the area defined by residues Lys-41, Arg-47, and Asp-48, in addition to the previously identified second aryl phosphate-binding pocket.

Original languageEnglish (US)
Pages (from-to)12406-12414
Number of pages9
JournalJournal of Biological Chemistry
Volume278
Issue number14
DOIs
StatePublished - Apr 4 2003
Externally publishedYes

Fingerprint

Non-Receptor Type 1 Protein Tyrosine Phosphatase
Crystal structure
Leptin
Isoenzymes
Catalytic Domain

ASJC Scopus subject areas

  • Biochemistry

Cite this

Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor. / Sun, Jin Peng; Fedorov, Alexander A.; Lee, Seung Yub; Guo, Xiao Ling; Shen, Kui; Lawrence, David S.; Almo, Steven C.; Zhang, Zhong-Yin.

In: Journal of Biological Chemistry, Vol. 278, No. 14, 04.04.2003, p. 12406-12414.

Research output: Contribution to journalArticle

Sun, JP, Fedorov, AA, Lee, SY, Guo, XL, Shen, K, Lawrence, DS, Almo, SC & Zhang, Z-Y 2003, 'Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor', Journal of Biological Chemistry, vol. 278, no. 14, pp. 12406-12414. https://doi.org/10.1074/jbc.M212491200
Sun, Jin Peng ; Fedorov, Alexander A. ; Lee, Seung Yub ; Guo, Xiao Ling ; Shen, Kui ; Lawrence, David S. ; Almo, Steven C. ; Zhang, Zhong-Yin. / Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor. In: Journal of Biological Chemistry. 2003 ; Vol. 278, No. 14. pp. 12406-12414.
@article{12c801b3c59d4a4092d58109a9daa9a7,
title = "Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor",
abstract = "Protein-tyrosine phosphatase 1B (PTP1B) has been implicated as an important regulator in several signaling pathways including those initiated by insulin and leptin. Potent and specific PTP1B inhibitors could serve as useful tools in elucidating the physiological functions of PTP1B and may constitute valuable therapeutics in the treatment of several human diseases. We have determined the crystal structure of PTP1B in complex with compound 2, the most potent and selective PTP1B inhibitor reported to date. The structure at 2.15-{\AA} resolution reveals that compound 2 simultaneously binds to the active site and a unique proximal noncatalytic site formed by Lys-41, Arg-47, and Asp-48. The structural data are further corroborated by results from kinetic analyses of the interactions of PTP1B and its site-directed mutants with compound 2 and several of its variants. Although many of the residues important for interactions between PTP1B and compound 2 are not unique to PTP1B, the combinations of all contact residues differ between PTP isozymes, which provide a structural basis for potent and selective PTP1B inhibition. Our data further suggest that potent, yet highly selective, PTP1B inhibitory agents can be acquired by targeting the area defined by residues Lys-41, Arg-47, and Asp-48, in addition to the previously identified second aryl phosphate-binding pocket.",
author = "Sun, {Jin Peng} and Fedorov, {Alexander A.} and Lee, {Seung Yub} and Guo, {Xiao Ling} and Kui Shen and Lawrence, {David S.} and Almo, {Steven C.} and Zhong-Yin Zhang",
year = "2003",
month = "4",
day = "4",
doi = "10.1074/jbc.M212491200",
language = "English (US)",
volume = "278",
pages = "12406--12414",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "14",

}

TY - JOUR

T1 - Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor

AU - Sun, Jin Peng

AU - Fedorov, Alexander A.

AU - Lee, Seung Yub

AU - Guo, Xiao Ling

AU - Shen, Kui

AU - Lawrence, David S.

AU - Almo, Steven C.

AU - Zhang, Zhong-Yin

PY - 2003/4/4

Y1 - 2003/4/4

N2 - Protein-tyrosine phosphatase 1B (PTP1B) has been implicated as an important regulator in several signaling pathways including those initiated by insulin and leptin. Potent and specific PTP1B inhibitors could serve as useful tools in elucidating the physiological functions of PTP1B and may constitute valuable therapeutics in the treatment of several human diseases. We have determined the crystal structure of PTP1B in complex with compound 2, the most potent and selective PTP1B inhibitor reported to date. The structure at 2.15-Å resolution reveals that compound 2 simultaneously binds to the active site and a unique proximal noncatalytic site formed by Lys-41, Arg-47, and Asp-48. The structural data are further corroborated by results from kinetic analyses of the interactions of PTP1B and its site-directed mutants with compound 2 and several of its variants. Although many of the residues important for interactions between PTP1B and compound 2 are not unique to PTP1B, the combinations of all contact residues differ between PTP isozymes, which provide a structural basis for potent and selective PTP1B inhibition. Our data further suggest that potent, yet highly selective, PTP1B inhibitory agents can be acquired by targeting the area defined by residues Lys-41, Arg-47, and Asp-48, in addition to the previously identified second aryl phosphate-binding pocket.

AB - Protein-tyrosine phosphatase 1B (PTP1B) has been implicated as an important regulator in several signaling pathways including those initiated by insulin and leptin. Potent and specific PTP1B inhibitors could serve as useful tools in elucidating the physiological functions of PTP1B and may constitute valuable therapeutics in the treatment of several human diseases. We have determined the crystal structure of PTP1B in complex with compound 2, the most potent and selective PTP1B inhibitor reported to date. The structure at 2.15-Å resolution reveals that compound 2 simultaneously binds to the active site and a unique proximal noncatalytic site formed by Lys-41, Arg-47, and Asp-48. The structural data are further corroborated by results from kinetic analyses of the interactions of PTP1B and its site-directed mutants with compound 2 and several of its variants. Although many of the residues important for interactions between PTP1B and compound 2 are not unique to PTP1B, the combinations of all contact residues differ between PTP isozymes, which provide a structural basis for potent and selective PTP1B inhibition. Our data further suggest that potent, yet highly selective, PTP1B inhibitory agents can be acquired by targeting the area defined by residues Lys-41, Arg-47, and Asp-48, in addition to the previously identified second aryl phosphate-binding pocket.

UR - http://www.scopus.com/inward/record.url?scp=0038662654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038662654&partnerID=8YFLogxK

U2 - 10.1074/jbc.M212491200

DO - 10.1074/jbc.M212491200

M3 - Article

VL - 278

SP - 12406

EP - 12414

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 14

ER -